Hair health sector sees growth in supplements and experimental treatments

The hair restoration and wellness sector is seeing developments in both consumer supplements and experimental medical therapeutics. FOLIKL has launched a new men’s supplement designed around a ‘Five Systems of Hair Longevity’ framework. The brand aims to proactively support hair growth, density, and pigment by focusing on follicle health and male vitality before visible hair loss occurs.

In the clinical sphere, research into androgenetic alopecia is exploring novel mechanisms of action beyond traditional DHT inhibition. Experimental compounds such as Breezula and PP405 are being studied for their ability to target androgen receptors and follicular stem cells. Additionally, hair cloning techniques are under investigation, though biological hurdles remain. Medical experts, including Dr. Raquel Amaro Silva of Hospital Capilar, note that while the field is in a period of significant innovation, rigorous validation is still required to transition these experimental treatments into proven clinical utilities.